Diabetes medication tirzepatide shows promise for treating sleep disorder

Eastern Mirror June 22, 2024, 11:00 PM UTC

Researchers have found tirzepatide, a diabetes medication, to be an effective treatment for Obstructive Sleep Apnea (OSA). The study, published in the New England Journal of Medicine, involved 469 participants with OSA. Tirzepatide led to a significant decrease in breathing interruptions during sleep, improving OSA severity. This breakthrough offers hope for the 936 million OSA patients globally, potentially reducing the need for CPAP therapy.


With a significance score of 5.4, this news ranks in the top 1% of today's 12832 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 8000 minimalists.